Nektar Therapeutics NKTR
Set alert
36.95 USD -1.92 -4.94%
At close · Nov 2
36.50 -0.45 -1.22%
After hours · Nov 2, 5:25 PM ET
36.81 Day range 39.01
33.40 52-week range 109.00
- YTD
- -12.61%
- 1 year
- -43.09%
- Open
- 38.65
- Prev close
- 38.87
- Mkt cap
- 1.26B
- Vol
- 823.21K
- Avg vol
- 1.10M
- EPS
- -18.96
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 36.81
- High
- 39.01
- Forward P/E
- -3.59
- Beta
- 1.42
- Short ratio
- 3.62
- Inst. own
- 107.23%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 55.69
- 200-d avg
- 65.01
- 1y target
- 133.08
Analyst view
Consensus: buy
Buy
Price target (mean) 133.08 +260.2% upside
Now 36.95
- Target (low)
- 50.00
- Target (mean)
- 133.08
- Target (high)
- 192.00
Ratings (0m) 15 11 buy · 4 hold · 0 sell
- Strong buy1
- Buy10
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.07 | -3.07 – -1.71 | -1.87 | -10.7% | 10.40M | -11.8% | 15 |
| Next quarter | -2.76 | -3.53 – -2.14 | -1.78 | -54.9% | 10.47M | -52.0% | 15 |
| Current year | -8.08 | -9.63 – -6.89 | -9.73 | +16.9% | 41.82M | -24.3% | 15 |
| Next year | -10.50 | -20.03 – -4.10 | -8.08 | -29.9% | 53.42M | +27.7% | 15 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | UBS | Initiated | — | Neutral |
| Oct 12, 2026 | Leerink Partners | Initiated | — | Outperform |
| Oct 9, 2026 | BTIG | Reiterated | Buy | Buy |
| Oct 9, 2026 | Raymond James | Initiated | — | Market Perform |
| Oct 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 28, 2026 | BTIG | Reiterated | Buy | Buy |
| Sep 25, 2026 | BTIG | Reiterated | Buy | Buy |
| Sep 23, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Sep 16, 2026 | BTIG | Reiterated | Buy | Buy |
| Sep 9, 2026 | BTIG | Reiterated | Buy | Buy |
| Jul 22, 2026 | Canaccord Genuity | Initiated | — | Buy |
| May 11, 2026 | Wedbush | Maintained | Neutral | Neutral |
| May 8, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Apr 21, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 21, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Apr 20, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 20, 2026 | BTIG | Maintained | Buy | Buy |
| Mar 24, 2026 | Wedbush | Initiated | — | Neutral |
| Mar 17, 2026 | TD Cowen | Initiated | — | Buy |
| Mar 16, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 23, 2026 | B. Riley Securities | Reiterated | Buy | Buy |
| Feb 10, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 10, 2026 | BTIG | Maintained | Buy | Buy |
| Jan 29, 2026 | BTIG | Reiterated | Buy | Buy |
| Dec 16, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 16, 2025 | BTIG | Maintained | Buy | Buy |
| Nov 26, 2025 | Citigroup | Initiated | — | Buy |
| Nov 26, 2025 | Jefferies | Maintained | Buy | Buy |
| Sep 23, 2025 | B. Riley Securities | Maintained | Buy | Buy |
| Sep 19, 2025 | BTIG | Reiterated | Buy | Buy |